Last Published 06.01.2026 Effective Date: 06.01.2026 This policy addresses the use of intravenous enzyme replacement drug products for the treatment of Gaucher disease, including Cerezyme (imiglucerase), Elelyso (taliglucerase), and VPRIV (velaglucerase)
Ginger and peppermint begin supporting digestive comfort from the first dose
The timeframe within the database(s) was from inception to 29th of November 2024 and the search was conducted by GLB
This revolutionary medication, originally developed to treat Type 2 diabetes, has proven benefits for improving blood pressure, lipid profiles, and weight management
Also Read : Why Indian Skin Needs Its Own Sunscreen Language There is an optimal concentration range for effective skin uptake, as penetration tends to plateau beyond certain levels, while excessively high concentrations may increase the risk of irritation